Transparency

The Kyowa Kirin Group has established "Transparency Policy for the Relationships between Corporate Activities, Healthcare Professionals, Healthcare Organizations and Patient Organizations" and strive to ensure our relationships among them in an ethical and transparent manner. We will commit to the public disclosure of information on the provision of funding to these stakeholders.

Kyowa Kirin Group Transparency Policy for the Relationships between Corporate Activities, Healthcare Professionals, Healthcare Organizations and Patient Organizations

Established on May 26, 2017
Revised on March 14, 2019

We at the Kyowa Kirin Group who strive to contribute to the health and well-being of people around the world collaborate with medical personnel and institutions (hereafter referred to collectively as "the Medical Community") and patient organizations in pursuit of innovative drug discovery, promotion of proper use of medication and patient-participatory medical care.
lol下注 We will ensure high ethical standards in our relationships with the Medical Community and patient organizations. To be accepted as a reliable corporate group in society, we will disclose the information on the transfer of values to the Medical Community and patient organizations (hereafter referred to as "Transparency") in line with the following principles.

  1. 1.
    We will act in the best interests of patients in our interactions with the Medical Community and patient organizations.
  2. 2.
    We will disclose information on the transfer of values to the Medical Community and patient organizations in countries where we operate, while complying with the related laws, guidelines and industry codes for Transparency.
  3. 3.
    We will establish and operate appropriate organizational structures and business processes to ensure timely and accurate disclosure in accordance with the above applicable laws, guidelines and industry codes.